Soumettre la recherche
Mettre en ligne
Km การดูแลผู้ป่วยได้รับยาละลายลิ่มเลือดในผู้ป่วยผ่าตัดลิ้นหัวใจ
•
0 j'aime
•
555 vues
sucheera Leethochawalit
Suivre
ยาละลายลิ่มเลือด
Lire moins
Lire la suite
Santé & Médecine
Signaler
Partager
Signaler
Partager
1 sur 18
Télécharger maintenant
Télécharger pour lire hors ligne
Recommandé
الجبر
الجبر
محمد الجمل
16º Circuito Paulista Universitário de surf 2014 - 1ª Etapa
16º Circuito Paulista Universitário de surf 2014 - 1ª Etapa
ibrasurf
الإستاتيكا
الإستاتيكا
محمد الجمل
15ª Circuito Paulista Universitário de Surf - 2ª Etapa
15ª Circuito Paulista Universitário de Surf - 2ª Etapa
ibrasurf
Une année au_cli_sp…_
Une année au_cli_sp…_
Réseau Pro Santé
Festival Universitário de Surf 2014
Festival Universitário de Surf 2014
Mari Peixoto
Festival Universitário de Surf 2014
Festival Universitário de Surf 2014
ibrasurf
Liminar acp caps
Liminar acp caps
Ministério Público de Santa Catarina
Recommandé
الجبر
الجبر
محمد الجمل
16º Circuito Paulista Universitário de surf 2014 - 1ª Etapa
16º Circuito Paulista Universitário de surf 2014 - 1ª Etapa
ibrasurf
الإستاتيكا
الإستاتيكا
محمد الجمل
15ª Circuito Paulista Universitário de Surf - 2ª Etapa
15ª Circuito Paulista Universitário de Surf - 2ª Etapa
ibrasurf
Une année au_cli_sp…_
Une année au_cli_sp…_
Réseau Pro Santé
Festival Universitário de Surf 2014
Festival Universitário de Surf 2014
Mari Peixoto
Festival Universitário de Surf 2014
Festival Universitário de Surf 2014
ibrasurf
Liminar acp caps
Liminar acp caps
Ministério Público de Santa Catarina
Liminar acp nasf
Liminar acp nasf
Ministério Público de Santa Catarina
LAB3-REPORT
LAB3-REPORT
Rupali Patel
Slownik
Slownik
Marcin Polak
Proyecto científico equipo onlyfive pd g
Proyecto científico equipo onlyfive pd g
onlifivepg
Measuring Agile Success
Measuring Agile Success
iwmontgomery
ETIS09 - Black Swans and White Elephants - Presentation
ETIS09 - Black Swans and White Elephants - Presentation
David Walker
IRM09 - What Can IT Really Deliver For BI and DW - Presentation
IRM09 - What Can IT Really Deliver For BI and DW - Presentation
David Walker
3rdchapter
3rdchapter
mtalupuru
Omg Bedeschi Company Profile
Omg Bedeschi Company Profile
MASSIMILIANO MESTRINER
CITIA08 - Ready For Change? - Presentation
CITIA08 - Ready For Change? - Presentation
David Walker
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اول
أمنية وجدى
Our Methodology
Our Methodology
riskevaluation
проект текст
проект текст
dfcbkmtdf
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اول
أمنية وجدى
2010 NEW YORK URBAN LATINO FILM FESTIVAL 2010
2010 NEW YORK URBAN LATINO FILM FESTIVAL 2010
synertainment4.0
Actions that vietnamese dislike
Actions that vietnamese dislike
Q&Me Vietnam Market Research
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...
OùSsama Elfalaki
القيادة وقت الازمات
القيادة وقت الازمات
Dr Ghaiath Hussein
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى
أمنية وجدى
Full Report
Full Report
Hatim Soeb Rangwala
Representing the curriculum symposium
Representing the curriculum symposium
Helen Beetham
ArcLight Cinemas
ArcLight Cinemas
Mike Jensen
Contenu connexe
Tendances
Liminar acp nasf
Liminar acp nasf
Ministério Público de Santa Catarina
LAB3-REPORT
LAB3-REPORT
Rupali Patel
Slownik
Slownik
Marcin Polak
Proyecto científico equipo onlyfive pd g
Proyecto científico equipo onlyfive pd g
onlifivepg
Measuring Agile Success
Measuring Agile Success
iwmontgomery
ETIS09 - Black Swans and White Elephants - Presentation
ETIS09 - Black Swans and White Elephants - Presentation
David Walker
IRM09 - What Can IT Really Deliver For BI and DW - Presentation
IRM09 - What Can IT Really Deliver For BI and DW - Presentation
David Walker
3rdchapter
3rdchapter
mtalupuru
Omg Bedeschi Company Profile
Omg Bedeschi Company Profile
MASSIMILIANO MESTRINER
CITIA08 - Ready For Change? - Presentation
CITIA08 - Ready For Change? - Presentation
David Walker
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اول
أمنية وجدى
Our Methodology
Our Methodology
riskevaluation
проект текст
проект текст
dfcbkmtdf
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اول
أمنية وجدى
2010 NEW YORK URBAN LATINO FILM FESTIVAL 2010
2010 NEW YORK URBAN LATINO FILM FESTIVAL 2010
synertainment4.0
Actions that vietnamese dislike
Actions that vietnamese dislike
Q&Me Vietnam Market Research
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...
OùSsama Elfalaki
القيادة وقت الازمات
القيادة وقت الازمات
Dr Ghaiath Hussein
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى
أمنية وجدى
Full Report
Full Report
Hatim Soeb Rangwala
Tendances
(20)
Liminar acp nasf
Liminar acp nasf
LAB3-REPORT
LAB3-REPORT
Slownik
Slownik
Proyecto científico equipo onlyfive pd g
Proyecto científico equipo onlyfive pd g
Measuring Agile Success
Measuring Agile Success
ETIS09 - Black Swans and White Elephants - Presentation
ETIS09 - Black Swans and White Elephants - Presentation
IRM09 - What Can IT Really Deliver For BI and DW - Presentation
IRM09 - What Can IT Really Deliver For BI and DW - Presentation
3rdchapter
3rdchapter
Omg Bedeschi Company Profile
Omg Bedeschi Company Profile
CITIA08 - Ready For Change? - Presentation
CITIA08 - Ready For Change? - Presentation
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اول
Our Methodology
Our Methodology
проект текст
проект текст
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اول
2010 NEW YORK URBAN LATINO FILM FESTIVAL 2010
2010 NEW YORK URBAN LATINO FILM FESTIVAL 2010
Actions that vietnamese dislike
Actions that vietnamese dislike
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...
القيادة وقت الازمات
القيادة وقت الازمات
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى
Full Report
Full Report
Similaire à Km การดูแลผู้ป่วยได้รับยาละลายลิ่มเลือดในผู้ป่วยผ่าตัดลิ้นหัวใจ
Representing the curriculum symposium
Representing the curriculum symposium
Helen Beetham
ArcLight Cinemas
ArcLight Cinemas
Mike Jensen
NETWORK REBRAND - pitch presentation (short version)
NETWORK REBRAND - pitch presentation (short version)
Stefano Di Ceglie
DiplomadoIABMex_Equipo6
DiplomadoIABMex_Equipo6
jorgemacias23
27thchapter
27thchapter
mtalupuru
Thai Alcoholic Beverages Regulations 2011
Thai Alcoholic Beverages Regulations 2011
Asian Food Regulation Information Service
Historiografía de la educación comie selección
Historiografía de la educación comie selección
nada
Nearby Startup Pitch for SUU 2013 conference
Nearby Startup Pitch for SUU 2013 conference
Adam Nemeth
Justin Hughes Press Release
Justin Hughes Press Release
Justin Michael
NGAGE-About us/UX
NGAGE-About us/UX
hspoeneman
NGAGEnow
NGAGEnow
NGAGE
Adapt, Collaborate, Innovate
Adapt, Collaborate, Innovate
Jim Smurro
Sani 2013 satisfaction.
Sani 2013 satisfaction.
Réseau Pro Santé
referente
referente
betsycaru
Requirements specification desingyourown_v2
Requirements specification desingyourown_v2
caramurf
a mirada dos espazos
a mirada dos espazos
MUSEO ETNOLOXICO
Skytide by the Numbers
Skytide by the Numbers
Patrick Hurley
Ppt wkc 18 novembre
Ppt wkc 18 novembre
Adriana Scuotto
33rdchapter
33rdchapter
mtalupuru
Commerce extérieur france 3e trimestre 2010
Commerce extérieur france 3e trimestre 2010
Ministère de l'Économie et des Finances
Similaire à Km การดูแลผู้ป่วยได้รับยาละลายลิ่มเลือดในผู้ป่วยผ่าตัดลิ้นหัวใจ
(20)
Representing the curriculum symposium
Representing the curriculum symposium
ArcLight Cinemas
ArcLight Cinemas
NETWORK REBRAND - pitch presentation (short version)
NETWORK REBRAND - pitch presentation (short version)
DiplomadoIABMex_Equipo6
DiplomadoIABMex_Equipo6
27thchapter
27thchapter
Thai Alcoholic Beverages Regulations 2011
Thai Alcoholic Beverages Regulations 2011
Historiografía de la educación comie selección
Historiografía de la educación comie selección
Nearby Startup Pitch for SUU 2013 conference
Nearby Startup Pitch for SUU 2013 conference
Justin Hughes Press Release
Justin Hughes Press Release
NGAGE-About us/UX
NGAGE-About us/UX
NGAGEnow
NGAGEnow
Adapt, Collaborate, Innovate
Adapt, Collaborate, Innovate
Sani 2013 satisfaction.
Sani 2013 satisfaction.
referente
referente
Requirements specification desingyourown_v2
Requirements specification desingyourown_v2
a mirada dos espazos
a mirada dos espazos
Skytide by the Numbers
Skytide by the Numbers
Ppt wkc 18 novembre
Ppt wkc 18 novembre
33rdchapter
33rdchapter
Commerce extérieur france 3e trimestre 2010
Commerce extérieur france 3e trimestre 2010
Plus de sucheera Leethochawalit
ตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdf
ตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdf
sucheera Leethochawalit
คู่มือโภชนากร
คู่มือโภชนากร
sucheera Leethochawalit
เอกสารประกอบการเรียนวิชาโภชนบำบัด
เอกสารประกอบการเรียนวิชาโภชนบำบัด
sucheera Leethochawalit
Chemo ebookสงขลา
Chemo ebookสงขลา
sucheera Leethochawalit
แนวเวชปฏิบัติโรคพิษสุนัขบ้า
แนวเวชปฏิบัติโรคพิษสุนัขบ้า
sucheera Leethochawalit
แนวทางการรักษาโรคหลอดเลือดสมองอุดตัน
แนวทางการรักษาโรคหลอดเลือดสมองอุดตัน
sucheera Leethochawalit
ตำราเภสัชกรรมไทย
ตำราเภสัชกรรมไทย
sucheera Leethochawalit
แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์
แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์
sucheera Leethochawalit
หลักทั่วไปในการให้วัคซีน
หลักทั่วไปในการให้วัคซีน
sucheera Leethochawalit
Antidote pocket guide v.3
Antidote pocket guide v.3
sucheera Leethochawalit
antidote y57
antidote y57
sucheera Leethochawalit
Plus de sucheera Leethochawalit
(11)
ตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdf
ตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdf
คู่มือโภชนากร
คู่มือโภชนากร
เอกสารประกอบการเรียนวิชาโภชนบำบัด
เอกสารประกอบการเรียนวิชาโภชนบำบัด
Chemo ebookสงขลา
Chemo ebookสงขลา
แนวเวชปฏิบัติโรคพิษสุนัขบ้า
แนวเวชปฏิบัติโรคพิษสุนัขบ้า
แนวทางการรักษาโรคหลอดเลือดสมองอุดตัน
แนวทางการรักษาโรคหลอดเลือดสมองอุดตัน
ตำราเภสัชกรรมไทย
ตำราเภสัชกรรมไทย
แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์
แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์
หลักทั่วไปในการให้วัคซีน
หลักทั่วไปในการให้วัคซีน
Antidote pocket guide v.3
Antidote pocket guide v.3
antidote y57
antidote y57
Dernier
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
Mohamed Rizk Khodair
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
Dr. Dheeraj Kumar
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
Niranjan Chavan
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
sdateam0
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
jennyeacort
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
Arunagarwal328757
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
saminamagar
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
virengeeta
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
MedicoseAcademics
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
bkling
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
Dr. Dheeraj Kumar
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
bkling
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
saminamagar
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
Kanhu Charan
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
Mumux Mirani
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
Dolisha Warbi
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
saminamagar
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
Dr.Nusrat Tariq
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
SasikiranMarri
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
Dr. Dheeraj Kumar
Dernier
(20)
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
Km การดูแลผู้ป่วยได้รับยาละลายลิ่มเลือดในผู้ป่วยผ่าตัดลิ้นหัวใจ
1.
2.
3.
!"#"$ %&'()*+),-+.$#/(,012 3456$)7839&0:3456$)7,-+.$1+" "9#
"99$3 1+" "9# 132*/$41) ;9#/( )!"< 3:/=>62+%"" 2 #)6+,-+.$1+ %4%6 283963%3 +:/ =>67%%"%3:"%?&5)!"< 37%" "9# %46"@1(%$0 2A BCDEF D GDDEFH &'( I J KFL#/( >#)6+%42M$98#"%&+,-+.$ N:032M 2 5 O3%"":7'72%47%"":%"72%"$:"-+) ,-+.$#/(:/N2+" '5<@()*+ 8$# "0$:%) PIQO3O 1"R ,-+.$ % M*%"":839 S"%"":6$)7 ;9,-+72# TU% VWWT
4.
V ! "# !$% &
' X เ<@( 8$# )%"2-83,-+.$#/(N2+" 393 34(:3@2%4 2)6+:/"94#Y4M< ,-+.$ 32M32M$98#"%&+ VX <@( 8$# )6+7+6 +#/()6 0$ O3%"":#" %;ZR0[KA [ E E] ^DK EH TX <@( 8$# )%""%?839%"< 3<@(8%+=>68 6 $4**/< (# X ,-+.$63,0123456$)7#/(7 1+" "9# 393 34(:3@2N2+-%1+ :" $ S:0[KN2+1:%;ZR#/(%6 2AM )!"< 3$ S:[K T 839,-+.$ 63,012:%%$0V_ $:K` D] $ S:[K WH :/8$# %"2-83,-+.$#/(:/M$9 ECDEF 0[K:%%$0%;ZR#/(%6 2 VX 32M$98#"%&+7%%"" "9# 393 34(:3@2%4 2#/("S8" N2+8%0 I a ]E TX ,-+.$#/(N2+" 393 34(:3@2 :"72%"% =>6N2+2+$1 !272%3S0:2-83 ,-+.$8 6 $4**/< APE EJ bbEJH !)" ` 1"[Kc T 63,0123456$)7)!"< 3%;ZR%6 2c VUdA7 $,-+.$ [Kc T e 7 $,-+.$#/(N2+" 393 34(:3@2: !"< 3)810392@ H ` 1"[Kc W 63,0123456$)7:%%$0V_ $%3:K ` D] c VUdA7 $,-+.$[K cW e7 $,-+.$#/(N2+" 393 34(:3@2: K` D] )!"< 3810392@ H ` 1"%"%42M$98#"%&+#/("S8",37% ECDEF ` I a ]E c UdA7 $,-+.$#/(%42 %"e7 $,-+.$#/(N2+" 393 34(: 3@2: K` D] 63,0123456$)7810392@ H ` %42753@21:1$ 3@2 %1:N"f=cVUdA7 $,-+.$#/(:/%"e7 $,-+.$#/( N2+" 393 34(:3@2: !"< 363,0123456$)7810392@ H
5.
T *+,-./001,2 gKBP DO3%"":%0,012AhiV jhiTH
DO3%"":63,012"99$4%k1A[IGH DO3%"":63,012"99<%flmAnioH 6+,012ABKH M*%"": # & 34 %563 "0$:42 X<X #$/O%24p !*14$q < ?RO38<#R S; @5AIrBH X<X *-O%24p %?:O 14p O38<#R S; $ArsH X X <"6:<" <*"-# 6$6 + %"< 36+,012 S;3441 X X :<" !1t94 6$6 + %"< 3O3%"": S;%47Ar H ;9< 3O3O 1"R uF bJJ S;%47Ar H %47%"": v6: e:/8$# 72%"=>6)%")6+%"2-83"%?,-+.$#/(N2+" 393 34(:3@2%4 263,0123456$)7 ! %")*+%"9$%"72%"$:"-+)%"8%+N =>6,-+.$N2+" 393 34(:3@2%4 263 ,0123456$)7#/(+:"%?)!"< 3 80= "0$:"+ "/ #/ " "S 9#+%3 "0$:w414 $2,3
6.
x ! $ S:8397268$# w414:@(%42=>67%!"8#"%&+63,-+.$"
"9# 393 34(: 3@2%4 2),-+.$63,0123456$)7 7 %"72%"$:"-+ryArEz D ] ] H %"9$%"#/(2 4%""0$:%!2,-+w414 6"@6 0$ 0) R%"<@("+839)*+$:"-+)%"<q )6+:/S;M<839%42,33<YR2/'5 !2 $ -0N%%"<q 6"@,-+w414 839<q { $:"-+ 6 0$ 6"@ R%"2 5%" 72%"$:"-+7' :" :)*+ "@(:@ 06 '()%"8%+=>6 6 0$ #/(%42'5)6+N2+ %"9$%"72%"$:"-+#/(2/839:/%""/"-+"0$:%"96$0 S3%"#/(798%+=>6 !2*0$%3(%" 6"@ "96R$:"-+7%,-+*/($*>8397%1" -0:@6"@ % "$4*%": $:"-+#/(S3%" :" N )*+)%"# <@(8%+N =>6N2+%"83% 3/( "/"-+%) "@(#/(%6 279%42"9!*R10,-+#/(2 "9 %";R6"@"9 =>68 2/$% :")*+$:"-+#/(N2+N8%+=>6N2+0 -%1+"$2"|$839 %42"9!*R-S210,-+" "4%"10N 6$6 +%3S0: O3O 1"RN2+%6 2! "97 })2+%" ,0123456$)7WUU" i},-+.$630/57 1+" "9# 393 34(:3@2 010 @(132N <@( v%N:0)6+%4234(:3@2N S21)"9 N63$/ "0% @(7% 2 #/()*+:/63 *42839 63 2*0 2#/()*+VjTjxjW ] 7'#)6+,-+.$%42$:,42<327%%"" "9# @(7%7N:0 N2+3@:" "9# 6"@" "9# &5#)6+%42=>6 %4 2!2)*+$4Y/1"$72-0[K%3S0: 15 N$+$00[K[Kc T %;ZR VUd7%%"~4142@ :%" :%|N2+•WXn d2@ %S:M< YR%|N2+ •xXh d2@ :/ :%|N2+•o d7% 414#/(:/828$!+:323 @(:7%S3%" %3S0: 1"96 %839)6+$: )%"2-83,-+.$%3S0:2%30$!2"0$:%8%+=>6 72#8$# ~414%" $4Y/" "9# k#Y4 ,3 / %"%42M$98#"%&+!2N2+" $:"0$::@#57%8<#R < 3M* %% M< 2839%!M* %" v6: <@()6+,-+.$" "9# 0 -%1+839 < : >146"@,-+2-83,-+.$)%+3*42*0$ </(3/5 1@6"@$ S%%%"" "9# )6+N2+,3 2/:%'5 0$) "@(%"9$%"72%"=>6)6+%""%?< 3N2+72#8$# %""%?#5 8<#R < 3"$:'#/:2-83)6+:/%" N)*+%,-+.$N2+)63 € %";R<@()6+,-+.$ 32M21$ 0#/( 79 10N /5
7.
W ! 8 6
9/:;/:1,+<-:=+>- # # ?@A ,-+.$<O6>4 SVo }63,012y•KJQ•Kb :@($#/(h <k?M :VWW 63,012 $ < =>6 ‚EzI DJE b 1+)*+"@(*0$< S6$)7A[uPH 637%5V $ $#/(_ <k?M : VWW ,-+.$ %"2/'5 :" B gQQa839z E "@(*0$< S6$)7A[uPH %N2+"4(:" "9# 393 34(:3@2$#/(o <k?M :VWW !28<#R)6+"4(:" "9# W ] B $ #/(VU<k?M :VWW N2+T ] B $#/(V <k?M :VWW N2+T ] B " T $ 791"$7,3 [K$#/(VV <k?M :VWW $3UhXUU X ,3%"79[K•oXV ,-+.$N:0:/%"8#"%&+ a D 7%$$9)2€ %"2-83"%?#/(N2+") [IG X BaFCM$9a D VX " 8<#R"#" # #/8<#R(%""%?,-+.$N2+" • r ]bX • jƒƒPV 839)6+ B 393 34(:3@2V $ TX 1"$7,3[K<@(Kb $3 _XUU X VT <k?M :VWW A1:%;ZR%6 2Kb 6 [K M ) Vx *:XH ,3N2+[K•Xn " 8<#R(%""%?)6+"4(:" "9# 393 34(:3@2)6:0 xX ,-+.$ %"#S3[K -0) %;ZR#/(%6 28<#R(+,-+.$ %7%[IGN<%"%?1$#/( Dnio 7+6 +#/(N2+010+:-3"@(%"" "9# 393 34(:3@2 ,-+.$%42 2 <@()6+7+6 +#/( D„v"9$,-+.$10 @(10N "S,-+.$ :"76 0%3 +N2+7%%"„v"9$N:0< [KPEE /% #'#&#!% B ,-+.$" /5,3[K -810N:0:/%"82 M$98#"%&+ *0:/3@2 %1:N"f=:@(:/%" 8"f=63B gQQa&'( w4%4"4#/(N:0N8$# 2/$%,-+.$ 7:/0#/(1(%$0/5%|N2+,3%" 1"$7 7N:0 7"4< 3 [IGN2+" $0:/%"1"$7 1:8$# ~414#/(%6 2 -083+$@ X Kb %"1"$7/%"5" ,3[K•oXV #0"58"% VX S3%"#/(793@2 2#%?9*0%"2-23@2 %:7% %"""7S)0Qa 3@2 01"$7 N:0:/8$# #/(*27 7%42%" lm "v%%"IE 3@2*0$ "4:k#Y4p TX )63%%" [IG79793@201"$71 *+!21"$7<"+:%#5IuI uEEDs uEEDIE839PQiPQQ!22-23@2VUJJ)0Qa 01"$7‚ax Qa %")0Qa N:0:/%"%6 2 $0)0QaN6 %083963!281039Qa79:/"v%%"8|1$ 3@2 -02 /5 `Qa IuI:/"g JJ JJ*0$)6+3@2N:0IE ` Qa uEEDs :/"sED]ƒED v%%"8|1$ 3@2839v%%")*+513 :|23@282
8.
h ` Qa uEEDIEN:0:/"9N" `
QaPQiPQQ:/sED]I v%%"8|1$ 3@2 xX /%"92|6 '(#/(0 "4: 61S#)6+%420[K,42%14@M$9 "0% ,-+.$%/($%!" 1#/(7#)6+%42k#Y4p "393 34(:3@2 3/(83 7%%"1"$7‚a#/(82 :""M<%" # 1!21"$7u a ,3:%%$0UUU&'(%4%$00%14:% 7#)6+!"1/#/()*+)%"8|1$ 3@2#/(1 "+ '5 -0) M<N:0<"+:)*+ %"8|1$ 3@27'*+%$0%14 7 C! X :/%"1"$7IE ])6:0#S%"5#/(< $00[K ,-+.$ -%40%14839N:0:/%" 8#"%&+!2%"793@2)6:0 VX %"2-23@27% 01"$7[K1+2-23@2<@()6+80)7$0N:0:/ b lm!2 2-23@2 %VUJJ%02-23@201"$7 TX 72#8$# %"""7SQa‚a:@(:/%"1"$73@2IE]b ‚a#S%"5"/322 /5 TX )0QauEEDJE TXV )0Qa PQiPQQ TXT )0QaIuI TXx )0QauEEDs xX 8<#R7)*+EF 393 34(:3@2323)" #/(:/M$91$ 6"@:/!"1"0$:2+$ ! D 6 9/:;/:1,+<-:=+>- # # ?@AE F-G/=.1HI ,-+.$6>4 Sx_ }63,012y•KJ‚ DJE J E :@($#/(VU%"%~ :VWx :/=>6 : !"< 3!"#"$ %:@(VT %S:M< YRVWxT 2+$ %" L8 08" <-2N:0N2+ 8<#R(1"$7[K,3Xx 83901"$7IQu ,3< I a JE8<#R)6+%""%?2+$ 839 % M< 2 -0!"< 3 W $ %"2/'5,-+.$"-+'%1$2/<-2N2+8 8|8"8<#R76 0 %3 +$#/(o :/ :VWxT ,-+.$:!"< 3"5/5$#/(x <k?M :VWW 2+$ %"&':3%0:!"< 3T $ <-2N:0 *2:/3@(N+7/ < 753@21:8 ` '!"< 3#/(6+…S%…479[K,3•nXh " 8<#R # #/
9.
n %""%?)6+6• r ]b•
8390# IQu ,3< saD ] E] 0 +[IG<@( )6+%"2-83"%?M$9…S%…483914210K ,-+.$N!"< 3@(<@("%?10) "@(!"# : #/( 71+N2+"%",012 7+6 +#/([IGN2+14210<@(K ,-+.$!2)*+%"9$%"2 /5 X < 3[J z D14210O-R@( "<@(14210!"< 3+ / #S%!"< 3#/( :",012: N2+!214210#/39!"< 3"4(:7%!"< 3)%3+/%0 *0!"< 3<"9 (%3+!"< 3 "O"2-"!"< 3*3"9# !"< 3M-:4<3 VX 8<#R$"6"@8<#R7+ N+79 S" 39 /2%8<#R !"< 3#/(14210 TX %";/ ,-+.$ 1""9% SM<1+14210 *X <@()6+*0$6!"< 3#/(79" K ,-+.$ xX<-2S%>14!28<#R839< 3#/(2-83<@("+ $: +)7%";/1+K ,-+.$N!" < 3@(839*/587 4#Y4)%"70 0"%?< 3 4#Y41+ %2 "9% SM< 839"9% :) !"< 3"{ 3 WX %";/>14N:0:/=>6# %"4 :"14210!"< 3 %* <@(K ,-+.$N"%?10 @(N2+<@()6+,-+.$N2+"%""%?#/("$2"|$ hX :@(14210N2+2 4%"1:51 %"K 1:%148390,-+.$N!2" ]a J <"+:% 7+6 +#/([IGN%" K 0,-+.$N!"< 3M-:4<3A"$:"99$3)%"14210 K N2+M ) h *($!:H # & F-;-: X )0gQQaEƒE†‡FJ 839EˆQa VX )6+ ‰_ ]X • F 637%5 ‰_ ] • #S%_ *: TX Š ‰WU]X • #S%_ *:X xX ƒƒPV • WX EaFC•isjis &%IF /5:"14210K N2+!2!"< 3M-:4<3",-+.$ @(7%,-+.$:/1""9% SM<#/(!"< 3M-:4<363K ,-+.$N "%""%?1083+$7+6 +#/([IGN2+!#"1421:,3%" "%?)$10:#" $0,-+.$N2+"%",012: saD ] E] 63,0122/'5•isFa 2/ =77S <%flm -0 DY"":2"-+'%1$2/<-2SN2+8 ` 8|8"2/ %";//5< $00[K -!2 :< YR% %"8#"%&+#/(%42'57%"9 %";R 1$ 0#/( #)6+7+6 +#/([IGN2+1"$7[K&5T "5!2 793@27%1$,-+.$ @ N2+$00[K -7"4
10.
_ $4"96R 61S$0#N:'%42[K -),-+.$"
/57%"9$14,-+.$ + -07X #S:Y / :" #/( !"#"$ %1328<#R ,-+" )6+,-+.$)6+"9$14$03@:" "9# "5 7'" "9# &5839 " "9# 8%+$22+$&'( 7 "4:k#Y4p 393 34(:3@2N2+ 810N:0 " "9# :SN<" 51 %"w414<@()6+,-+.$" "9# N2+-%1+:%'5 X )6+,-+.$839>14< M*%"<@( $4Y/" "9# )6+-%1+ VX )6+>14,-+2-83,-+.$*0$1@8391"$7 )6+,-+.$" "9# N2+1"1: (8<#R TX :/:S2<%"971$,-+.$#/()6++:-3%/($%!"#/( %",012#/(N2+" "4:; #/(" "9# 1+ xX 89 ,-+.$839>1463/%3/(%"" "9# 6"839 63 *42#/("4:k#Y4p 393 34(:3@2*0 6"7<$%,%) /$6"@ 6"7 8%+$2 :SN<" 1+ WX 89 ,-+.$ +!"%" J J #' J ,-+.$" /5N2+"%""%?< 3#/("$2"|$!2< 36+…S%…4 :"1"$7"9:4 %"< M$98#"%&+8391"$70[KN2+,3"|$8<#R01"$7IQu # #/<"+:" ,3,-+.$:/saD ] E] "9 % z D[IG<@(0 D] 839 :")6+%""%? @51+N2+# #/(7%,3IQ u 8<#R6| :$"$01+K N"%""%?10# : #/(!"< 3@(< 3[IG)*+8$# %"14210K #/(:/-014210N2+"$2"|$ :" K N2+M ) h *:X839,-+.$N2+"%",012: N2+"|$ 7'N2+" $:32M %"2/'5%3 @-0M$9%14N2+"92|2+%""%? ;9 -0) [IG<@(" K ,-+.$N2+"%""%?1::1"{ $4**/< " +$ !2N2+"%"I z†*0$6 )7N2+" %v : N2+",341M;ZR 3@2<@(*93%"u D#/(: 3,3%"w414#56:2#)6+,-+.$2/'5'8:+79 N2+"%",012: "0% %|flm1$"|$N:0%42!"8#"%&+ :<k%?R:< 1:/*/$41"232M839:/ S;M<*/$41#/(2/ ! 3KJ@LM:/1, ! # 9/:=?@ANGF/O X6 0$ !#"87+7S22 "RVVV <@( 21"$7IQ VX8<#R,-+ 21"$7!#""'%?" /8<#R TX6 0$ 0$*"9 /39ƒ]<"+:)1"$72:#/(7S21"$7<4O? xX7S22$*"9 /839ƒ] "'%?" /8<#R WX%";/"020$ 7+6 +#/(!#"87+6 0$ # #/ hX %";/N:0"020$#1:51 %"21"$78 %14
11.
o nX%"2IQg] J†# #/#N2+M
) VU #/63 ] "@(:@ ! P 6 B 9/:= QRP ,-+.$* N# - S:!"< 32+$ %"6 @( 6 S6: V ) "9$14V $%0: !"< 3!"#"$ %N !"< 3<S#Y*4"*<4?;S!3%8<#R" 393 34(:3@27%V ] W ] $39 "5 :!"< 3!"#"$ % D] DhiT 8"%",-+.$"-+'%1$2/:/M$9&/279[K•xXo JX VxdN:0:/753@21:1$ :/"9$1402 }To 839}xT 8<#R$447… ECDEF839 ] A "9$1463,012y•K }VWVn )*+F T]H J X )6+• r U] • F VX PKIV • ‹‚F‰VU]X • %0)6+3@2 ` 63N2+" 3@2,3 JVhdA U:X X VWW H 839TUdA :X XVWW H "5/5,-+.$N:0:/021"$7 sEEEJJ aEEDKuI•U` 810N:0N2+1"$76< Y4839N:0N2+IEF ] E,-+.$ 7:/!" 3@2N2+ 63N2+"%""%?,-+.$ %"2/'58<#R76 0%3 +$#/(V :X XW "$: !"< 3T $ 3 S! !TQRP3 # 6 6 U X "9:4 M$9,-+.$8"%" &%"9$14%"" "9# 393 34(:3@22-753@21:1$ VX 1421:,3IQŒ[KŒ J<"+:" 8<#R"971'% TX 2 393 34(:3@2 xX 2-83)6+N2+" 3@2<"+: %1M$98#"%&+7%%")6+3@2 WX !#"O<#R87+M*%"<@()6+ "'%?"@($4Y/%"" "9# 393 34(:3@2#/(32M,-+.$ 1$ 0#/(T + -01076$2:ƒEEz b#/(!"#"$ %:@(:/%"0$)6>079ƒiG -0#/(!"< 3 <S#Y*4"*7X<4?;S!3%" "9# 393 34(:3@2N:0N2+1:%;ZR#/(%6 27%%"#/(M*%"N S% ,-+.$839>14"@(%"" "9# 393 34(:3@2< $024:# V ]iD†810:/=>6 "@(%"N7'N "%?< 3#/(!"< 3<S#Y*4"*8<#R)6+8%+N839" 3/( 393 34(:3@2 W ]iD†,-+ .$ w4Y%"" "9# @("0$:2+$6"@ 6"#/(3/(N7%%147'N:0:/=77 @(#/(79#)6+%42 ECDEF
12.
U 8$# w414<@(<q 10N
+8<#R790,-+.$%3 ƒiG!"< 3)%3++#S%" 79N2+" :S2<%"971$,-+.$#/()6++:-3%/($%!"#/( %",012#/(N2+" "4:; #/(" "9# <@( 8$# )6+8<#R#($N "97!"< 31076$2)*+w414%,-+.$" 5€ %7%/5%3S0: O3O 1"RN2+72"4%""'%? =>6 SM<!2< 3z Dnio 1 =>66"@)6+89 % 20$ "RUV`W__T W 10nooU`oT N2+132$3Vx *($!: C! # ! # 9/:=?@A C!B 3 # X1"$7 $:-%1+ 3@26"@0$ "9% 3@2#/(4%:7%6+3@2!2)*+7+6 +#/( V 839:/%"3 #'% 3 3%?;R%?"2 /5 `*42 3@2 0$ "9% 3@2-%1+1:1+%" ` 3#/())%% 3@21"%…3% S""7S `*@(,-+"47 ))%% 3@21"%…3% S""7S `uEED ,-+"47 ))%%1"%…3% S""7S8391"% uEED ,-+.$ `1"$7 $ "47 839$6:2 S 3@2 VX1"$7 $:"/"+ S""7S:/" "($…/% 2…3%3 3@6"@N:0 TX M< /3%?;9 3@2 0$ "9% 3@2,42%146"@N:0 xX)*+*S2)6+3@2#/(:/1$%" 2 nUN:" 8399 2"O7%*@5 WX 3@2 -42N:0$")6+ %4x *($!: hX %1 #'% %"• F ;9)6+3@283963)6+3@2 nX 03@21"$76 $: +:+ 3@263%")6+3@2<@("9:4,3 C!B # X" ‚F,0121"$7 *@( %S3 1'%,-+.$ VX 1"/:Qa <4:<R14%%"R142)6+*27 TX 793@21"$7ˆEb3@2 uB u723‚F,0122+$ "@( /#/(*27 xX 721"/:!3641)6+<"+:)*+-%1+839</< WX 3@26:-0<4O?K !#"87+8<#R8396+,012# #/#/(1"$77 hX 14210 3@26:-0<4O?N#/(%*28391421:#S%$7%$079N2+3@2 nX72#) 3@28%/1:6:-03@2<@(32$: /( 3+3@2,42S _X:/"9 %"1"$7 !2)*+7+6 +#/(V %076 03@2
13.
&% 7%%"O'%?#5T 1$ 0#/(%30$:79<
$0 =>6 ,-+.$#/(" "9# 393 34(:3@2%4 2 ECDEF 5:/!% %42N2+63%63 %";R:/#55N:0"S8"N:0%42,3 /10,-+.$ 7 '%42M$98#"%&+"S8" ',-+.$ /*/$41%"$4"96R=>6< 15810%42<"9S3%" 2$:"-+ 839#%?9)%"2-83,-+.$#/(" "9# 393 34(:3@2 /%%";/@%427%1$,-+.$ #/(2$:"-+$: +)7)%"" "9# 393 34(:3@2*07N:0N2+2 " "9# &5 1+ 61S#/(#)6+ ,-+.$%42M$9 ECDEF2 5# %3S0: O3O 1"R7'6|$: >)%"#/(79"+ %"9$%"72%"#/(2/:/%"@( "$:"-+<@(%""/"-+"0$:%"96$0 S3%"#/(798%+=>6 $:"-+#/( w41483+$N2+,32/:)*+) $#/83% 3/( "/"-+6" S3%")839 %%3S0: O3O 1"R<@( 8 0)6+ @(€ :" N)*+:@("9 =>68 2/$%N2+ %7%/5:/8$42#/(7972%3S0:,-+.$ <@()6+:"2-831$ N2+) "@(%"" "9# 393 34(:3@28 PE EJ bbEJ!2%")6+ $:"-+,-+.$839>148 6 $4**/< <@($ S:%"" "9# 393 34(:3@2:/%" )6+,-+.$ :/$:"-+) "@(%"" "9# 393 34(:3@2839w4141$ 07"47"-+$4Y/" "9# 0 -%1+,3 %"" "9# :%6"@+ %4N 7 ' :" 793@21"$7N2+2+$1$ #" ,33@2"$2"|$ :" "'%?8<#R<@((%""%?N2+%0#/(,-+.$79%42M$98#"%&+ %"" "S%"9$%" 2-83,-+.$#/(" "9# 393 34(:3@28 (@ 010 @(10N
14.
V VW1=-X1,- M$9 393 34(:3@2%4
2A BCDEFH 6: '%"#/(,3 393 34(:3@2 % k#Y4p:%%$0%;ZR#/(%6 2!22-7%0[KA[ E E] ^DK EH 839%3S0: O3O 1"R !"#"$ %:/8$# O38<#RAˆ D H )%")6+393 34(:3@2210N /5 X ,-+.$,0123456$)7 •K‹yJ J CC 0[K #0% XW` VXU VX ,-+.$,0123456$)7 •K‹yJ J CC‹FL JE 0[K #0% VXU` VXW TX ,-+.$,0123456$)7y•K‹yJ J CC 0[K #0% X_` VXT xX ,-+.$,0123456$)7y•K‹yJ J CC‹FL JE 0[K #0% X_` VXW WX ,-+.$,0123456$)7 •K‹yJ J CC 0[K #0% VXU` VXW hX ,-+.$,0123456$)7 •K‹uEbEF JCC 0[K#0% XW` VXUA" "9# 393 34(:3@2 "99$3T 2@H nX ,-+.$,0123456$)7 •K‹uEbEF JCC ‹KFL JE 0[K#0% VXU` VXW _X ,-+.$,0123456$)7Q•K‹yJ J CC 0[K#0% VXW` TXU oX ,-+.$,0123456$)7Q•K‹uEbEF JCC 0[K#0% V` VXW A" "9# 393 34(: 3@2 "99$3T 2@H UX ,-+.$,0123456$)7y•Kb 0[K#0% XW` VXUA" "9# 393 34(:3@2 "99$3T 2@H X ,-+.$,0123456$)7y•Kb ‹KFL JE 0[K#0% XW` VXU VX ,-+.$#/(N:0N2+,0123456$)78101+" "9# @(7%:/M$9%"1+ 6$)7,42%14 *42 ƒa E 0[K#0% XW` VXU
15.
T YX+Z 9/:;/:1,+<-:=+>- )[F 8$#
%")6+%""%?,-+.$M$9 BC DEFƒEz)*+) gKBP ,-+.$#/( $079:/ M$9 ECDEFN2+8%0,-+.$#/(" "9# :@(:/M$92 /5 X:/0 PQi[K bEE c E A1" #/(H VX:/%"839 %"82 M$93@2 %A1" #/(VH ! 8V+/XL/:2-H EF J JF •QjPgjƒj• C DFF XW`VXW s J JF ` •KEy•KE •KAuEbF FFH• ` •KAyJ JH `y•KAyJ JH ` •KAyJ JH `Q•KAuEbF FFH `Q•KAyJ JH `y• b • •6: 61S" "9# z T 2@6"@,012%";/sK XW`VXU XW`VXU X_`VXW VXU`VXW VXU`VXW VXW`TXU XW`VXU ! D12,/,=O.0H+.+;]X--=1,2 XsbE EFa F VXu D ]F TXgb FF xXP J igJJ†]EFF WX ] hX ] ]FF nXy i ] EJ ^ _X ]Eb†FF oXB a D EFFbJ J ]E ! P^0H1+,+;Z/:;/:1,:-<-:>/X Q†bE CF bbEJ `KbDA U` W ] H `ƒFAb H `PE]bAx`h FH `sEzAVx FXH `G FEzAECD†FH PIIA PE E]a JE]b‰JEJ H WUiL X ƒƒPAU`WJJiL XH [•C ] r W`U]X B C ] rVXW`W]X B] z DEF
16.
xGuideline of Treatment Suspect
warfarin overdose 1.Check PT INR, CBC (1" #/(1) 2.S/S of bleeding (1" #/(2) 3.Review dose of warfarin and indication 4.Other medication, antiplatelet, NSAID 5.Underling liver, renal disease Above therapeutic but <5.0 >5.0 but < 9.0 No bleeding No bleeding Admit ward -Old age > 70 Yrs -Poor compliance -Previous bleeding complication Admit ward -Lower dose or stop -Monitor PT INR -Notify resident CVT or staff (Admit ward) -Stop warfarin -Monitor PT INR -Notify resident/staff CVT (D/C) -no bed -no S/S of major bleeding -good complicance education -no Hx of bleeding -F/U OPD early visit -Admit -stop warfarin -Vitamin K 5-10 mg. -Monitor PT INR in 24 hrs -Notify resident or staff CVT Admit -stop warfarin -Vitamin K 10 mg. -FFP -Monitor PT INR & control in 24 hrs. -Notify resident/staff CVT D/C F/U OPD CVT #/()%3+#/(S26"@1"$7% Staff 7+ N+ Lower dose or Stop warfarin Major bleeding but not serious Patient evaluation risk Low risk High risk -Age > 70 -Hx stroke TIA UGIB -Hepato renal failure -On antiplatlet Major bleeding
17.
W>9.0 -admit ward -stop warfarin -vitamin
K 10 mg. -monitor PT INR -notify resident/staff CVT -admit -stop warfarin -vitamin K 10 mg. -FFP -monitor PT INR -notify resident/staff CVT -admit -stop warfarin -vitamin K 10 mg. -FFP -monitor PT INR -notify resident/staff CVT %";/ Intra cranial ]E - notify staff X-Ray -CT brain Ergent - 14210Refer - +Refer N:0N2+admit obsevere ICU !21+notify staff CVT %0 <@(6 1/ 10N No bleeding Major bleeding or Major bleeding -resuscitation shock -ET if ressesity -vitamin K 10 mg. FFP -G/M -notify staff/resident CVT !220$ -Admit ICU -Life threatening bleeding -hemodynamic unstable -stroke -suspect intracranial ]E *** >20 (very high PT INR )(confirm not error) Any PT INR
18.
h 5 % %3S0: M
*%"": !" #"$ %X % & E_12`aX-:Hb:W2Ic VWx_X S;;k%?R# 7"4>X AVWxUHX 1+% "81$ 3@2* 42" "9# X & 3 d # jUAHj`V : :8<# R!" 6$)7860 "9#ON# X &% 7! d # J Be! c VWWUX " N<""S;X ! Be!B Ea,H1f+/2WX/,HIX !" #"$ %X VWWUX y LƒX r jP ] jIIPjIˆP DP †‚EDjKX VUU_X 9/:;/:1,g/,/2-@+,>1=-:/H1+,1, h+,2iL-:.@/:-Y/f1X1H1->X ] J ˆ JFsEJ †X ŽEF EbLFG CF†sJEEE yDJ X y L X IEz jy jysJX u D KFLE X
Télécharger maintenant